Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IMMUNE GLOBULIN NOS for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where IMMUNE GLOBULIN NOS was used for Multiple sclerosis.

Most Reported Side Effects for IMMUNE GLOBULIN NOS

Side Effect Reports % Deaths Hosp.
Drug ineffective 963 42.8% 228 533
Off label use 675 30.0% 113 334
Drug ineffective for unapproved indication 266 11.8% 69 143
Condition aggravated 207 9.2% 31 138
Product use in unapproved indication 143 6.4% 31 52
Therapy non-responder 130 5.8% 14 82
Treatment failure 121 5.4% 12 36
Septic shock 95 4.2% 31 86
Diarrhoea 92 4.1% 9 74
Maternal exposure during pregnancy 83 3.7% 1 40
Vomiting 83 3.7% 6 67
Nausea 81 3.6% 4 54
Drug intolerance 77 3.4% 1 67
Disease progression 67 3.0% 14 22
Intentional product use issue 67 3.0% 14 37

Other Indications for IMMUNE GLOBULIN NOS

Product used for unknown indication (292) Immune thrombocytopenia (100) Haemophagocytic lymphohistiocytosis (98) Immunosuppressant drug therapy (98) Dermatomyositis (92) Covid-19 (83) Myasthenia gravis (63) Encephalitis autoimmune (52) Interstitial lung disease (48) Juvenile idiopathic arthritis (47)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) GLATIRAMER (27,144) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105)

Related Pages

IMMUNE GLOBULIN NOS Full Profile All Multiple sclerosis Drugs IMMUNE GLOBULIN NOS Demographics IMMUNE GLOBULIN NOS Timeline